Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 133Neoplasms 114Prostatic Neoplasms 63Lung Neoplasms 47Head and Neck Neoplasms 46Colorectal Neoplasms 35Ovarian Neoplasms 33Uterine Cervical Neoplasms 28Endometrial Neoplasms 23Motor Activity 22Neoplasm Metastasis 20Multiple Myeloma 19Brain Neoplasms 19Pancreatic Neoplasms 18Rectal Neoplasms 17Lymphoma 16Fatigue 16Carcinoma, Non-Small-Cell Lung 16Pain 15Gastrointestinal Neoplasms 15Colonic Neoplasms 15Leukemia 14Depression 14Oropharyngeal Neoplasms 13Urinary Bladder Neoplasms 12Melanoma 12Hematologic Neoplasms 12Esophageal Neoplasms 12Anxiety Disorders 12Stomach Neoplasms 11

Interventions

testosterone undecanoate 3Testosterone 3testosterone 17 beta-cypionate 1Triptorelin Pamoate 1Testosterone Propionate 1Tamoxifen 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Orchiectomy 1Observation 1Methyltestosterone 1Mental Status and Dementia Tests 1Gonadotropin-Releasing Hormone 1Gels 1Drug Evaluation 1Clomiphene 1Castor Oil 1Blood Specimen Collection 1Anastrozole 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypogonadism × Surveys and Questionnaires × Clear all
NCT00529230 2018-10-25

Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes

M.D. Anderson Cancer Center

Terminated
46 enrolled

Hypogonadism, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡